‘Precision medicine’ targets diabetes
Researchers have developed a “precision medicine” approach to diabetes designed to single out those who can benefit most from drugs or lifestyle changes.
The researchers looked at 17 health factors, including blood sugar readings and waist-to-hip ratios, for each patient. Seven of the factors mattered most. No genetic tests were needed.
The study was published in the British Medical Journal and included scientists from the University of Michigan in Ann Arbor, VA Ann Arbor Healthcare System and Tufts Medical Center in Boston.
The researchers want to turn the model into a tool for doctors to use with patients who have “pre-diabetes,” according to a release from the University of Michigan.
“This really shows that within the realm of pre-diabetes there’s a lot of variation, and that we need to go beyond single risk factors and look holistically at who are the people in whom a particular approach works best.” said Dr. Jeremy Sussman, lead author of the study and an assistant professor at the University of Michigan Medical School.
From Forbes on Wednesday: “[T]wo companies with billions at stake—Genentech and Regeneron Pharmaceuticals — are slugging it out over a trial that sought to determine who has the best eye drug for many people with diabetes. Neither company paid for the study or controlled its design, but Regeneron was able to walk away declaring victory.”
The companies were in head-to-head over whose drug would show the most improvement in a Nationals Institutes of Health study of 660 patients with diabetic macular edema.
Regeneron’s afilbercept showed greater improvement than Genentech’s ranibizumab.
Curiously, MedicalXpress reported Wednesday that ranibizumab reversed vision loss, based on a study at the University of Southern California (USC) Eye Institute.
Dr. Pamela Wible offers good advice, not just for PWDs, but all patients, on how to get the most out of your doctor. And saying “Thank you” is on the list. Who’d’a thunk?
Want to pass on a news tip? You can reach me at firstname.lastname@example.org